.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

METADATE CD Drug Profile

« Back to Dashboard
Metadate Cd is a drug marketed by Ucb Inc and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has thirteen patent family members in eight countries.

The generic ingredient in METADATE CD is methylphenidate hydrochloride. There are thirty-one drug master file entries for this compound. Thirty-five suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the methylphenidate hydrochloride profile page.

Summary for Tradename: METADATE CD

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Drug Prices: :see details

Pharmacology for Tradename: METADATE CD

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc
METADATE CD
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021259-003May 27, 2003RXNo6,344,215► subscribeY ► subscribe
Ucb Inc
METADATE CD
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021259-004Feb 19, 2006RXNo6,344,215► subscribeY ► subscribe
Ucb Inc
METADATE CD
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021259-001Apr 3, 2001RXNo6,344,215► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: METADATE CD

Drugname Dosage Strength RLD Submissiondate
metformin hydrochlorideExtended-release Capsules40 mgMetadate CD3/15/2007
metformin hydrochlorideExtended-release Capsules10 mg, 20 mg and 30 mgMetadate CD5/13/2005

International Patent Family for Tradename: METADATE CD

Country Document Number Estimated Expiration
European Patent Office2269605► subscribe
Poland361673► subscribe
Norway20031843► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc